The Chairman of the Supervisory Board, Dr. Thomas Rabe, said: "We've been working with Dr. Heinz-Jürgen Bertram very successfully and in a spirit of trust for many years. We are therefore pleased to reaffirm his appointment as CEO for a further five years before his contract is up for renewal. Dr. Bertram has been part of the Executive Board for more than ten years and has worked with Symrise for nearly three decades. He has accelerated the pace of the company's international development and diversification. Symrise has an excellent reputation among its customers and in the capital market. With the early renewal of Dr. Bertram's contract, we are ensuring the Group’s continued successful development.“